-- ============================================================================
-- BATCH 20: Additional Blood and Blood Products (Questions 788-847)
-- Topic: Advanced transfusion medicine and complications
-- ============================================================================

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES

-- MASSIVE TRANSFUSION
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Massive transfusion is traditionally defined as:',
'Transfusion of 5 units of blood',
'Replacement of entire blood volume (10 or more units) in 24 hours',
'Any blood transfusion',
'Transfusion over 1 week',
'Only plasma transfusion',
'B',
'Massive transfusion: Replacement of entire blood volume (approximately 10 units in adult) in 24 hours, or 4 or more units in 1 hour, or replacement of 50% blood volume in 3 hours.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Massive transfusion protocols typically involve:',
'RBCs only',
'Balanced ratio of RBCs, FFP, and platelets (approximately 1:1:1)',
'Platelets only',
'Crystalloids only',
'No protocol needed',
'B',
'MTP: Balanced resuscitation with RBC:FFP:Platelets approximately 1:1:1 prevents dilutional coagulopathy. Early activation based on clinical assessment (ABC score, trauma severity).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Complications of massive transfusion include all EXCEPT:',
'Hypothermia',
'Hyperkalemia',
'Hypocalcemia from citrate',
'Improved coagulation',
'Dilutional coagulopathy',
'D',
'Massive transfusion complications: Hypothermia (cold products), hyperkalemia (stored blood), hypocalcemia (citrate binds calcium), dilutional coagulopathy, ARDS, transfusion reactions.',
'medium', 'comprehension'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Citrate toxicity in massive transfusion causes:',
'Hyperkalemia',
'Hypocalcemia leading to cardiac dysfunction and coagulopathy',
'Hypernatremia',
'Hypercalcemia',
'No significant effects',
'B',
'Citrate in blood products binds calcium. Massive transfusion overwhelms liver metabolism. Results in hypocalcemia causing cardiac dysfunction, hypotension, and impaired coagulation.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Treatment of citrate toxicity during massive transfusion involves:',
'Stopping transfusion',
'IV calcium gluconate or calcium chloride supplementation',
'Sodium bicarbonate',
'Potassium replacement',
'Warming only',
'B',
'Citrate toxicity: Give calcium gluconate 10% 10 mL IV or calcium chloride (more potent but irritant). Monitor ionized calcium. Typically needed after every 4-6 units in rapid transfusion.',
'medium', 'application'),

-- TRANSFUSION THRESHOLDS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Current evidence supports a restrictive transfusion threshold of:',
'Hb 10 g/dL for all patients',
'Hb 7 g/dL for most stable patients without cardiac disease',
'Hb 12 g/dL for all patients',
'No specific threshold',
'Always transfuse to Hb 14 g/dL',
'B',
'Restrictive strategy: Transfuse at Hb 7 g/dL for stable non-cardiac patients. Liberal threshold (8-10 g/dL) for acute coronary syndrome, symptomatic anemia. Avoid unnecessary transfusion.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'In acute coronary syndrome, the transfusion threshold is typically:',
'Hb 7 g/dL',
'Hb 8-10 g/dL (more liberal)',
'Hb 5 g/dL',
'No transfusion needed',
'Hb 14 g/dL',
'B',
'ACS and cardiac patients: Higher threshold (Hb 8-10 g/dL) due to decreased oxygen-carrying capacity affecting ischemic myocardium. Balance risks of anemia versus transfusion.',
'medium', 'application'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'One unit of packed RBCs typically raises hemoglobin by approximately:',
'0.5 g/dL',
'1 g/dL',
'3 g/dL',
'5 g/dL',
'0.1 g/dL',
'B',
'Expected rise: 1 unit PRBC raises Hb by approximately 1 g/dL (or Hct by 3%) in average adult. Less if bleeding continues, hemolysis, or increased blood volume.',
'easy', 'knowledge'),

-- COMPONENT THERAPY DETAILS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Cryoprecipitate contains concentrated:',
'Red blood cells',
'Fibrinogen, Factor VIII, vWF, Factor XIII, fibronectin',
'All clotting factors',
'Platelets',
'Albumin',
'B',
'Cryoprecipitate: Precipitate from thawed FFP. Contains fibrinogen, Factor VIII, vWF, Factor XIII, fibronectin. Used for hypofibrinogenemia, DIC, massive transfusion, von Willebrand disease.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Fibrinogen concentrate compared to cryoprecipitate:',
'Is less pure',
'Is pathogen-reduced with standardized fibrinogen content',
'Contains more factors',
'Has longer storage',
'Is identical',
'B',
'Fibrinogen concentrate: Virally inactivated, standardized dosing, no ABO matching needed, longer shelf life. Increasingly used for hypofibrinogenemia instead of cryo.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Prothrombin Complex Concentrate (PCC) contains:',
'Only Factor VIII',
'Factors II, VII, IX, X (with or without protein C and S)',
'All clotting factors',
'Platelets',
'Only fibrinogen',
'B',
'PCC: Contains vitamin K-dependent factors (II, VII, IX, X). 4-factor PCC also has protein C and S. Used for urgent warfarin reversal, Factor deficiencies, massive bleeding.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'For urgent reversal of warfarin in major bleeding, the preferred treatment is:',
'Fresh frozen plasma alone',
'4-factor PCC plus IV vitamin K',
'Oral vitamin K only',
'No treatment needed',
'Recombinant Factor VIIa',
'B',
'Warfarin reversal in major bleeding: 4-factor PCC (25-50 units/kg) provides rapid reversal within minutes. Plus IV vitamin K 10 mg for sustained effect. FFP is slower and requires larger volumes.',
'medium', 'application'),

-- SPECIAL PRODUCTS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Irradiated blood products are indicated for:',
'All transfusions',
'Immunocompromised patients, HSCT recipients, intrauterine transfusions',
'Trauma patients only',
'Elective surgery only',
'Patients with normal immunity',
'B',
'Irradiation: Prevents TA-GVHD by inactivating donor lymphocytes. Indications: HSCT, congenital immunodeficiency, intrauterine transfusion, directed donations from relatives, certain chemo regimens.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'CMV-negative blood products are indicated for:',
'All patients',
'CMV-negative pregnant women, neonates, immunocompromised awaiting transplant',
'CMV-positive patients',
'Trauma patients',
'Elective surgery',
'B',
'CMV-negative products: Prevent CMV transmission to susceptible patients (CMV-negative pregnant, neonates, CMV-negative HSCT recipients). Leukoreduction also reduces CMV risk.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Washed RBCs are indicated for:',
'All transfusions',
'Patients with severe allergic reactions or IgA deficiency',
'Routine surgery',
'Chronic anemia',
'Blood type O patients',
'B',
'Washed RBCs: Plasma proteins removed. For recurrent severe allergic/anaphylactic reactions, IgA deficiency with anti-IgA antibodies, paroxysmal nocturnal hemoglobinuria.',
'medium', 'knowledge'),

-- TRANSFUSION REACTIONS DETAIL
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The most common type of transfusion reaction is:',
'Acute hemolytic reaction',
'Febrile non-hemolytic transfusion reaction (FNHTR)',
'Anaphylaxis',
'TRALI',
'TA-GVHD',
'B',
'FNHTR: Most common reaction. Fever, chills without hemolysis. Due to cytokines from WBCs or recipient antibodies to donor WBCs. Reduced by leukoreduction. Generally benign.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The most common cause of fatal transfusion reactions is:',
'Febrile reactions',
'TRALI (Transfusion-Related Acute Lung Injury)',
'Allergic reactions',
'Bacterial contamination',
'Circulatory overload',
'B',
'TRALI: Leading cause of transfusion-related mortality. Non-cardiogenic pulmonary edema within 6 hours. Due to anti-WBC antibodies in donor plasma. No specific treatment; supportive care.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'TRALI is characterized by:',
'Volume overload',
'Acute respiratory distress within 6 hours with bilateral infiltrates and no cardiac cause',
'Hemolysis',
'Fever only',
'Delayed reaction after days',
'B',
'TRALI: Acute dyspnea, hypoxia, bilateral pulmonary infiltrates within 6 hours of transfusion. Non-cardiogenic (normal PCWP). No pre-existing lung injury. Most recover with supportive care.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'TACO (Transfusion-Associated Circulatory Overload) differs from TRALI by:',
'Being identical',
'Signs of volume overload, elevated BNP, response to diuretics',
'Causing hemolysis',
'Occurring after days',
'Having lower mortality',
'B',
'TACO: Volume overload - JVD, hypertension, elevated BNP, S3 gallop, pulmonary edema. Responds to diuretics. TRALI: Normal/low BP, normal BNP, no diuretic response. Both cause respiratory distress.',
'medium', 'comprehension'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Prevention of TACO includes:',
'Faster transfusion',
'Slower transfusion rate, diuretics, limit volume in at-risk patients',
'Using whole blood',
'No prevention possible',
'Higher volumes',
'B',
'TACO prevention: Identify at-risk (elderly, cardiac disease, renal impairment). Slow infusion (1-2 hours per unit), prophylactic diuretics, limit unnecessary transfusion.',
'medium', 'application'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Bacterial contamination of blood products most commonly affects:',
'Fresh frozen plasma',
'Platelets (stored at room temperature)',
'Packed RBCs',
'Cryoprecipitate',
'Albumin',
'B',
'Platelets: Highest bacterial contamination risk because stored at room temperature (20-24 degrees C). Screening implemented but risk remains. RBCs at 4 degrees C have lower risk.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Signs of septic transfusion reaction include:',
'Low fever only',
'High fever, rigors, hypotension, DIC developing during or shortly after transfusion',
'Urticaria',
'Delayed hemolysis',
'No symptoms',
'B',
'Septic reaction: High fever (over 2 degrees C rise), rigors, hypotension, shock, DIC. Occurs during or within hours. Stop transfusion, culture blood and product, antibiotics, supportive care.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Delayed hemolytic transfusion reaction occurs:',
'During transfusion',
'Days to weeks after transfusion due to anamnestic antibody response',
'Within 1 hour',
'Never',
'Within 6 hours',
'B',
'Delayed HTR: 1-28 days post-transfusion. Anamnestic response - antibodies from prior sensitization that were undetectable. Presents with falling Hb, mild jaundice, positive DAT.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Post-transfusion purpura (PTP) is:',
'Common reaction',
'Rare thrombocytopenia 5-12 days post-transfusion from anti-platelet antibodies',
'Allergic reaction',
'Immediate hemolysis',
'Fever',
'B',
'PTP: Rare but severe. Severe thrombocytopenia 5-12 days after transfusion. Anti-HPA antibodies destroy both donor and patient platelets. Treat with IVIG, plasmapheresis.',
'hard', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Transfusion-associated graft-versus-host disease (TA-GVHD):',
'Is easily treated',
'Has greater than 90% mortality and is prevented by irradiation',
'Only affects blood donors',
'Is common',
'Causes fever only',
'B',
'TA-GVHD: Donor lymphocytes attack recipient tissues. Occurs in immunocompromised. Pancytopenia, rash, liver dysfunction, diarrhea. More than 90% mortality. Prevention: Irradiation inactivates lymphocytes.',
'medium', 'knowledge'),

-- SPECIAL SITUATIONS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'In emergency when blood type is unknown, the safest RBC product to give is:',
'Type A positive',
'Type O negative (universal donor)',
'Type AB positive',
'Type B negative',
'Any available type',
'B',
'Emergency unknown type: O negative RBCs (universal donor - no A, B, or D antigens). Limited supply - switch to type-specific once available. O positive acceptable for males and non-childbearing females.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'For plasma transfusion, the universal donor is:',
'Type O',
'Type AB (no anti-A or anti-B antibodies)',
'Type A',
'Type B',
'Any type',
'B',
'Plasma: AB is universal donor (no anti-A or anti-B antibodies to react with recipient cells). Opposite of RBC transfusion where O is universal donor.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Transfusion in Jehovahs Witness patients:',
'Follows standard protocols',
'Requires discussion of alternatives and respect for autonomous refusal',
'Is always performed',
'Has no legal considerations',
'Cannot be refused',
'B',
'Jehovahs Witness: Respect autonomous refusal of blood. Document carefully. Discuss alternatives: Cell salvage (acceptable to some), hemodilution, erythropoietin, iron, minimize blood loss.',
'medium', 'application'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Autologous blood transfusion includes:',
'Using donors blood',
'Preoperative donation, acute normovolemic hemodilution, cell salvage',
'Random donor blood',
'Emergency O negative blood',
'No specific techniques',
'B',
'Autologous transfusion: Preoperative donation (stored for later use), acute normovolemic hemodilution (dilute before surgery, retransfuse after), cell salvage (intraoperative collection and reinfusion).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Cell salvage (intraoperative blood salvage) is contraindicated in:',
'Major cardiac surgery',
'Surgery with malignancy or infection at the surgical site (relative)',
'Orthopedic surgery',
'Trauma surgery',
'Vascular surgery',
'B',
'Cell salvage contraindications (relative): Malignancy (risk of tumor cell reinfusion - can use leukocyte filters), contamination/infection, amniotic fluid (risk of AFE - modern systems may be safe).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Neonatal transfusion considerations include:',
'Same as adult transfusion',
'Smaller volumes, CMV-negative, irradiated products for at-risk neonates',
'Larger volumes',
'No special considerations',
'Using maternal blood always',
'B',
'Neonatal transfusion: Small aliquots (10-20 mL/kg), CMV-negative or leukoreduced, irradiated for certain indications, avoid potassium load (use fresh or washed RBCs).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Iron overload from chronic transfusion occurs after approximately:',
'1-2 transfusions',
'10-20 units or more (each unit contains approximately 250 mg iron)',
'100 units',
'Never occurs',
'500 units',
'B',
'Transfusional iron overload: Each RBC unit contains approximately 200-250 mg iron. Body has limited excretion. After 10-20 units, iron accumulates in heart, liver, endocrine organs. Treat with chelation.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Iron chelation therapy in transfusion-dependent patients:',
'Is never needed',
'Removes excess iron using agents like deferoxamine, deferasirox',
'Adds more iron',
'Is contraindicated',
'Uses blood letting only',
'B',
'Iron chelation: Deferoxamine (SC/IV infusion), deferasirox (oral - once daily), deferiprone (oral). Indicated for chronic transfusion patients (thalassemia, sickle cell). Monitor ferritin and organ iron.',
'medium', 'knowledge');
